Elanco Animal Health (ELAN) Free Cash Flow (2017 - 2026)
Elanco Animal Health (ELAN) posted Free Cash Flow of -$38.0 million for Q1 2026, down 182.61% sequentially from $46.0 million in Q4 2025, and up 44.93% YoY from -$26.2 million in Q1 2025.
Elanco Animal Health (ELAN) Free Cash Flow (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Free Cash Flow for 10 years, with the latest figure at -$38.0 million in Q1 2026.
- Quarterly Free Cash Flow rose 44.93% year-over-year to -$38.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $315.0 million (down 9.22% YoY) and the FY2025 annual result came in at $284.0 million, down 27.92% from the prior year.
- Free Cash Flow eased to -$38.0 million in Q1 2026 per ELAN's latest filing, from $46.0 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $261.0 million in Q2 2022 and troughed at -$169.0 million in Q1 2023.
- A 5-year average of $61.9 million and a median of $116.0 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow sank 1825.0% in 2022, then soared 773.68% in 2024.
- Over 5 years, Free Cash Flow stood at -$64.0 million in 2022, then jumped by 281.25% to $116.0 million in 2023, then advanced by 12.07% to $130.0 million in 2024, then plunged by 64.62% to $46.0 million in 2025, then sank by 182.61% to -$38.0 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$38.0 million, $46.0 million, and $127.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 137.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 244.00 Mn |
| Jun 30, 2026 | 244.00 Mn |
| Mar 31, 2026 | -38.00 Mn |
| Mar 31, 2026 | -38.00 Mn |
| Dec 31, 2025 | 46.00 Mn |
| Dec 31, 2025 | 46.00 Mn |
| Sep 30, 2025 | 127.00 Mn |
| Sep 30, 2025 | 127.00 Mn |
| Jun 30, 2025 | 180.00 Mn |
| Jun 30, 2025 | 180.00 Mn |
| Mar 31, 2025 | -69.00 Mn |
| Mar 31, 2025 | -69.00 Mn |
| Dec 31, 2024 | 130.00 Mn |
| Dec 31, 2024 | 130.00 Mn |
| Sep 30, 2024 | 120.00 Mn |
| Sep 30, 2024 | 120.00 Mn |
| Jun 30, 2024 | 166.00 Mn |
| Jun 30, 2024 | 166.00 Mn |
| Mar 31, 2024 | -22.00 Mn |
| Mar 31, 2024 | -22.00 Mn |